Deregulated microRNA (miR)/transcription factor (TF)-based networks represent a hallmark of cancer. We report here a novel c-Myc/miR-23b/Sp1 feed-forward loop with a critical role in multiple myeloma (MM) and Waldenstrom's macroglobulinemia (WM) cell growth and survival. We have found miR-23b to be downregulated in MM and WM cells especially in the presence of components of the tumor bone marrow milieu. Promoter methylation is one mechanism of miR-23b suppression in myeloma. In gain-of-function studies using miR-23b mimics-transfected or in miR-23b-stably expressing MM and WM cell lines, we observed a significant decrease in cell proliferation and survival, along with induction of caspase-3/7 activity over time, thus supporting a tumor suppressor role for miR-23b. At the molecular level, miR-23b targeted Sp1 3'UTR and significantly reduced Sp1-driven nuclear factor-kappa B activity. Finally, c-Myc, an important oncogenic transcription factor known to stimulate MM cell proliferation, transcriptionally repressed miR-23b. Thus MYC-dependent miR-23b repression in myeloma cells may promote activation of oncogenic Sp1-mediated signaling, representing the first feed-forward loop with critical growth and survival role in myeloma.

miR-23b/SP1/c-myc forms a feed-forward loop supporting multiple myeloma cell growth / M. Fulciniti, N. Amodio, R.L. Bandi, A. Cagnetta, M.K. Samur, C. Acharya, R. Prabhala, P. D'Aquila, D. Bellizzi, G. Passarino, S. Adamia, A. Neri, Z.R. Hunter, S.P. Treon, K.C. Anderson, P. Tassone, N.C. Munshi. - In: BLOOD CANCER JOURNAL. - ISSN 2044-5385. - 6:1(2016 Jan), pp. e380.1-e380.8. [10.1038/bcj.2015.106]

miR-23b/SP1/c-myc forms a feed-forward loop supporting multiple myeloma cell growth

A. Neri;
2016

Abstract

Deregulated microRNA (miR)/transcription factor (TF)-based networks represent a hallmark of cancer. We report here a novel c-Myc/miR-23b/Sp1 feed-forward loop with a critical role in multiple myeloma (MM) and Waldenstrom's macroglobulinemia (WM) cell growth and survival. We have found miR-23b to be downregulated in MM and WM cells especially in the presence of components of the tumor bone marrow milieu. Promoter methylation is one mechanism of miR-23b suppression in myeloma. In gain-of-function studies using miR-23b mimics-transfected or in miR-23b-stably expressing MM and WM cell lines, we observed a significant decrease in cell proliferation and survival, along with induction of caspase-3/7 activity over time, thus supporting a tumor suppressor role for miR-23b. At the molecular level, miR-23b targeted Sp1 3'UTR and significantly reduced Sp1-driven nuclear factor-kappa B activity. Finally, c-Myc, an important oncogenic transcription factor known to stimulate MM cell proliferation, transcriptionally repressed miR-23b. Thus MYC-dependent miR-23b repression in myeloma cells may promote activation of oncogenic Sp1-mediated signaling, representing the first feed-forward loop with critical growth and survival role in myeloma.
transcription factors; waldenstrom macroglobulinemia; therapeutic implications; SP1 transactivation; mir-23B expression; antitumor-activity; tumor-suppressor; cancer; gene; family
Settore MED/15 - Malattie del Sangue
gen-2016
Article (author)
File in questo prodotto:
File Dimensione Formato  
Fulciniti_Blood Cancer J_2016.pdf

accesso aperto

Descrizione: Articolo principale
Tipologia: Publisher's version/PDF
Dimensione 1.43 MB
Formato Adobe PDF
1.43 MB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/358166
Citazioni
  • ???jsp.display-item.citation.pmc??? 33
  • Scopus 53
  • ???jsp.display-item.citation.isi??? 51
social impact